The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal c
| Image |  |
|---|---|
| Description | scientific article published on 16 October 2011 |
| Author/s |
author: Bridget-Anne Kirwan Imran Ali |
| Publication date | October 16, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |